Tag: Cytokinetics
Market: Novartis in advanced discussions for the acquisition of Cytokinetics
(Reuters) – Swiss laboratory Novartis is in advanced discussions to acquire Cytokinetics in a transaction that could value the American biopharmaceutical company at more than $10 billion (9.14 billion euros),…